Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Prolonged response to TPO-R agonists
Dr James Bussel - Cornell University, Ithaca, USA
Prolonged response to TPO-R agonists ( Dr James Bussel - Cornell University, Ithaca, USA )
4 Sep 2014
Effects of one TPO-R agonist after discontinuing another?
Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany
Effects of one TPO-R agonist after discontinuing another? ( Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany )
4 Sep 2014
New players and targets in tumour vasculature
Dr Ugo Cavallaro - European Institue of Oncology, Milan, Italy
New players and targets in tumour vasculature ( Dr Ugo Cavallaro - European Institue of Oncology, Milan, Italy )
27 Aug 2014
ecancermedicalscience editor's choice for July and August 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for July and August 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Aug 2014
Melanoma live: Making patient-focused therapy decisions
Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long
Melanoma live: Making patient-focused therapy decisions ( Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long )
1 Aug 2014
ReDO project finds ways of repurposing generic drugs as beneficial cancer...
Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium
ReDO project finds ways of repurposing generic drugs as beneficial cancer treatments ( Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium )
10 Jul 2014
Repurposing generics to fight cancer and the work of the ReDO Project
Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Repurposing generics to fight cancer and the work of the ReDO Project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
10 Jul 2014
Continual low-dose metronomic chemotherapy as potentially preferable to...
Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel
Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies ( Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel )
10 Jul 2014
Metronomics and low/middle income countries, especially in breast cancer
Dr Alexandru Eniu - Cancer Institute Ion Chiricuta Cluj-Napoca, Cluj-Napoca...
Metronomics and low/middle income countries, especially in breast cancer ( Dr Alexandru Eniu - Cancer Institute Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania )
10 Jul 2014
Looking for biomarkers in metronomic chemotherapy
Prof Guido Bocci - University of Pisa, Pisa, Italy
Looking for biomarkers in metronomic chemotherapy ( Prof Guido Bocci - University of Pisa, Pisa, Italy )
10 Jul 2014
New metronomic approach to neuroblastoma
Prof Frank Berthold - University Hospital Köln, Köln, Germany
New metronomic approach to neuroblastoma ( Prof Frank Berthold - University Hospital Köln, Köln, Germany )
10 Jul 2014
Cost-effectiveness of metronomic approach to neuroblastoma and its use in...
Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )
10 Jul 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation